EYEPOINT PHARMACEUTICALS INC (EYPT) Stock Cash Flow
NASDAQ:EYPT - Nasdaq - US30233G2093 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -146.78M | -130.87M | -70.80M | -102.25M | -58.42M | |||
| Depreciation Amortization | 1.73M | 1.54M | 464.00K | 2.45M | 2.77M | |||
| Income Taxes - Deferred | N/A | 90.00K | N/A | N/A | N/A | |||
| Change In Working Capital | -27.97M | -27.77M | 58.97M | -3.02M | -1.74M | |||
| Interest Paid | N/A | 0.00 | 1.41M | 2.60M | 4.85M | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 24.75M | 30.79M | 13.24M | 37.83M | 7.29M | |||
| OPERATING CASH FLOW | -148.18M | -126.23M | 1.88M | -65.01M | -50.10M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -3.13M | -4.05M | -3.48M | -2.15M | -160.00K | |||
| Other Investing Activity | -197.50M | -215.30M | 168.00K | -15.12M | -32.97M | |||
| INVESTING CASH FLOW | -200.64M | -219.35M | -3.31M | -17.27M | -33.12M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -140.00K | -105.00K | -40.51M | 2.10M | -150.00K | |||
| Stock Issued/Repurchased | 165.34M | 169.31M | 229.55M | 400.00K | 217.20M | |||
| Other Financing Activity | -2.25M | -5.18M | -1.97M | -3.19M | -150.00K | |||
| FINANCING CASH FLOW | 162.96M | 164.02M | 187.07M | -690.00K | 216.90M | |||
| Exchange Rate Effect | N/A | N/A | N/A | N/A | 0.00 | |||
| CHANGE IN CASH | -185.85M | -181.56M | 185.63M | -82.97M | 133.68M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -148.18M | -126.23M | 1.88M | -65.01M | -50.10M | |||
| Capital Expenditure | -3.13M | -4.05M | -3.48M | -2.15M | -160.00K | |||
| FREE CASH FLOW | -151.31M | -130.28M | -1.61M | -67.16M | -50.26M | |||
All data in USD